How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
Does your choice of DMARD/biologics change due to increased risk of malignancy?
Answer from: at Academic Institution
The presence of hereditary polyposis coli and its predisposition to colon cancer should have little effect on the management of RA.
Available data indicate that methotrexate has at best a neutral effect on predisposition to malignancy. There are data to suggest that the combination of methotrexate ...